(Q39475407)

English

Immortalized chick embryo cell line adapted to serum-free growth conditions and capable of replicating human and reassortant H5N1 influenza strains for vaccine production

scientific article published on 10 September 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 September 2017

Immortalized chick embryo cell line adapted to serum-free growth conditions and capable of replicating human and reassortant H5N1 influenza strains for vaccine production (English)

1 reference

Europe PubMed Central

12 September 2017

0 references

author name string

Paul M Coussens

1

1 reference

Europe PubMed Central

12 September 2017

Kristen A Smith

2

1 reference

Europe PubMed Central

12 September 2017

Patty S D Weber

3

1 reference

Europe PubMed Central

12 September 2017

Christopher J Colvin

4

1 reference

Europe PubMed Central

12 September 2017

language of work or name

0 references

publication date

10 September 2011

1 reference

Europe PubMed Central

12 September 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

12 September 2017

29

1 reference

Europe PubMed Central

12 September 2017

8661-8668

1 reference

Europe PubMed Central

12 September 2017

47

1 reference

Europe PubMed Central

12 September 2017

describes a project that uses

0 references

Replicative advantage in tissue culture of egg-adapted influenza virus over tissue-culture derived virus: implications for vaccine manufacture

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.122

7 January 2021

Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.122

7 January 2021

Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.122

7 January 2021

Development of a mammalian cell (Vero) derived candidate influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.122

7 January 2021

The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.122

7 January 2021

Effects of egg-adaptation on the receptor-binding properties of human influenza A and B viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.122

7 January 2021

Influenza vaccines: recent advances in production technologies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.122

7 January 2021

Antigenic and structural characterization of multiple subpopulations of H3N2 influenza virus from an individual

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.122

7 January 2021

Evidence for host-cell selection of influenza virus antigenic variants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.122

7 January 2021

Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.122

7 January 2021

Selection of receptor-binding variants of human influenza A and B viruses in baby hamster kidney cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.122

7 January 2021

Influenza: propagation, quantification, and storage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.122

7 January 2021

Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.122

7 January 2021

Antibody response to immunization with influenza A/USSR/77 (H1N1) virus in young individuals primed or unprimed for A/New Jersey/76 (H1N1) virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.122

7 January 2021

Defective interfering influenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.122

7 January 2021

High titer growth of human and avian influenza viruses in an immortalized chick embryo cell line without the need for exogenous proteases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.122

7 January 2021

African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.122

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2011.08.122

1 reference

Europe PubMed Central

12 September 2017

1 reference

Europe PubMed Central

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39475407&oldid=1830018536"